Complete response of stage IV pancreatic cancer combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range hyperthermia

March 2019, European Journal of Cancer 110(1): S22

(DOI:10.1016/j.ejca.2019.01.073)

April 2019, ITOC 6 Conference, poster presentation